1
|
Mastorodemos V, Ioannides S, Papadaki E, Mitsias P. Posterior reversible encephalopathy syndrome in a patient with multiple sclerosis. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
2
|
Mastorodemos V, Vourakis G, Georgiakakis G, Mitsias P. Anti-TNFa-associated central nervous system demyelination. A triggering factor for multiple sclerosis? J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
3
|
Mastorodemos V, Vogiatzi E, Latsoudis H, Vorgia P, Amoiridis G, Zaganas I. Limb-girdle muscular dystrophy due to a novel homozygous ISPD gene mutation disclosed by whole exome sequencing. J Neurol Sci 2015. [DOI: 10.1016/j.jns.2015.08.1205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
4
|
Fanouriakis A, Mastorodemos V, Pamfil C, Sidiropoulos P, Bertsias G, Boumpas DT. AB0388 Coexistence of systemic lupus erythematosus and multiple sclerosis. prevalence and natural history. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.2710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
5
|
Kotzamani D, Panou T, Mastorodemos V, Tzagournissakis M, Nikolakaki H, Spanaki C, Plaitakis A. Rising incidence of multiple sclerosis in females associated with urbanization. Neurology 2012; 78:1728-35. [DOI: 10.1212/wnl.0b013e31825830a9] [Citation(s) in RCA: 83] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
6
|
Vlachou K, Fanouriakis A, Glymenaki M, Ioannou M, Mastorodemos V, Verginis P, Boumpas D. Defects within the Myeloid Derived Supressor Cells (MDSCS) Compartment may Facilitate Aberrant Immune Responses in Systemic Lupus Erythematosus (SLE). Ann Rheum Dis 2012. [DOI: 10.1136/annrheumdis-2011-201238.29] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
7
|
Mastorodemos V, Nikolakaki H, Tzagournissakis M, Kotzamani D, Panou T, Spanaki C, Klados G, Maris T, Kontolaimaki E, Psaroudaki K, Chlouverakis G, Georgakakis G, Plaitakis A. Benign multiple sclerosis in Crete. Mult Scler 2010; 16:701-6. [DOI: 10.1177/1352458510364631] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Our objective was to study multiple sclerosis on Crete, an island of 0.6 million inhabitants sharing a similar genetic background and the same environment. Case ascertainment was achieved using the MS Epidemiology Program Project of Crete. The diagnosis and classification of multiple sclerosis were made by established clinical and magnetic resonance imaging criteria, and disease evolution was assessed by periodic evaluations. Thorough clinical and laboratory evaluations were conducted; a detailed history, including a questionnaire of 36 items, was taken. Data obtained were analysed for possible interaction with disease prognosis. We identified 587 cases of multiple sclerosis (F:M = 1.6), >90% of which were of Cretan origin from both parental lines. Age at onset was 31.5 ± 10.3 years (mean ± SD) and disease duration 12.7 ± 9.1 years. About 84.6% had relapsing remitting multiple sclerosis, 9.4% primary progressive multiple sclerosis and 6% clinically isolated syndrome. Nearly 40% of our multiple sclerosis patients with disease duration >10 years (mean = 16.2 ± 5.3 years) remained with no or mild disability (Expanded Disability Status Scale [EDSS] ≤3). Also, about 30% of patients with relapsing remitting multiple sclerosis showed benign disease evolution (EDSS ≤3) more than 20 years (mean = 24.0 ± 3.3) after onset. Factors predisposing to benign multiple sclerosis included younger age at onset, shorter disease duration and a lower number of relapses. We conclude that a substantial proportion of patients with multiple sclerosis from Crete follow a rather benign disease course, and this may relate to the genetic background of the population and/or to environmental factors.
Collapse
Affiliation(s)
- V. Mastorodemos
- Department of Neurology and the Neurology Service of the University Hospital, School of Health Sciences, University of Crete, Heraklion, Crete, Greece
| | - H. Nikolakaki
- 2nd Neurology Department General Hospital, Chania, Crete, Greece
| | - M. Tzagournissakis
- Department of Neurology and the Neurology Service of the University Hospital, School of Health Sciences, University of Crete, Heraklion, Crete, Greece
| | - D. Kotzamani
- Department of Neurology and the Neurology Service of the University Hospital, School of Health Sciences, University of Crete, Heraklion, Crete, Greece
| | - T. Panou
- Department of Neurology and the Neurology Service of the University Hospital, School of Health Sciences, University of Crete, Heraklion, Crete, Greece
| | - C. Spanaki
- Department of Neurology and the Neurology Service of the University Hospital, School of Health Sciences, University of Crete, Heraklion, Crete, Greece
| | - G. Klados
- Venizeleio General Hospital, Heraklion, Crete, Greece
| | - T. Maris
- Venizeleio General Hospital, Heraklion, Crete, Greece, 1st Neurology Department, General Hospital, Chania, Crete, Greece
| | | | | | - G. Chlouverakis
- Department of Biostatistics, School of Health Sciences, University of Crete, Heraklion, Crete, Greece
| | - G. Georgakakis
- 2nd Neurology Department General Hospital, Chania, Crete, Greece
| | - A. Plaitakis
- Department of Neurology and the Neurology Service of the University Hospital, School of Health Sciences, University of Crete, Heraklion, Crete, Greece,
| |
Collapse
|
8
|
Mastorodemos V, Mamoulaki M, Kritikos H, Plaitakis A, Boumpas DT. Central nervous system involvement as the presenting manifestation of autoimmune rheumatic diseases: an observational study using the American College of Rheumatology nomenclature for neuropsychiatric lupus. Clin Exp Rheumatol 2006; 24:629-35. [PMID: 17207377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
OBJECTIVE We sought to describe CNS involvement as initial presentation of autoimmune rheumatic diseases using a standardized nomenclature. PATIENTS AND METHODS A 6-year observational study (1999-2005) was conducted in the University Hospital of Heraklion Crete, a regional referral secondary/tertiary care academic center. Patients presenting with new neurological symptoms of acute/subacute onset underwent clinical and laboratory screening for systemic autoimmune disorders. The diagnosis of an autoimmune rheumatic disorder was based upon the American College of Rheumatology (ACR) classification criteria, whereas for primary antiphospholipid syndrome (PAPS) we used the Sapporo preliminary criteria. In order to describe the neurological syndromes we used the ACR nomenclature for neuropsychiatric lupus. RESULTS During this period fourteen patients (ten females and four males) were recorded. Eight patients had systemic lupus erythematosus (SLE), four had primary APS and the remaining two had systemic vasculitis. Four out of the eight SLE patients had secondary APS. Two of them presented with movement disorder (chorea). The other two and all four patients with primary APS presented with cerebrovascular disease (CVD). These six patients comprised the 5.7% of young adults under < 45 years old with cerebrovascular accident admitted over the 6-year period. CONCLUSION SLE and APS either primary or secondary to SLE were the most common underlying systemic autoimmune rheumatic diseases, in patients presenting with a neurological event of acute onset. Young adults (< 45 years old) with CVD should undertake screening for SLE/APS.
Collapse
Affiliation(s)
- V Mastorodemos
- Department of Neurology, School of Health Sciences University of Crete, Heraklion, Greece
| | | | | | | | | |
Collapse
|
9
|
Papadaki HA, Tsagournisakis M, Mastorodemos V, Pontikoglou C, Damianaki A, Pyrovolaki K, Stamatopoulos K, Fassas A, Plaitakis A, Eliopoulos GD. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis. Bone Marrow Transplant 2005; 36:1053-63. [PMID: 16205726 DOI: 10.1038/sj.bmt.1705179] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Bone marrow (BM) stem cell reserves and function and stromal cell hematopoiesis supporting capacity were evaluated in 15 patients with multiple sclerosis (MS) and 61 normal controls using flow cytometry, clonogenic assays, long-term BM cultures (LTBMCs) and enzyme-linked immunosorbent assays. MS patients displayed normal CD34+ cell numbers but a low frequency of colony-forming cells (CFCs) in both BM mononuclear and purified CD34+ cell fractions, compared to controls. Patients had increased proportions of activated BM CD3+/HLA-DR+ and CD3+/CD38+ T cells that correlated inversely with CFC numbers. Patient BM CD3+ T cells inhibited colony formation by normal CD34+ cells and patient CFC numbers increased significantly following immunomagnetic removal of T cells from BMMCs, suggesting that activated T cells may be involved in the defective clonogenic potential of hematopoietic progenitors. Patient BM stromal cells displayed normal hematopoiesis supporting capacity indicated by the CFC number in the nonadherent cell fraction of LTBMCs recharged with normal CD34+ cells. Culture supernatants displayed normal stromal derived factor-1 and stem cell factor/kit ligand but increased flt-3 ligand levels. These findings provide support for the use of autologous stem cell transplantation in MS patients. The low clonogenic potential of BM hematopoietic progenitors probably reflects the presence of activated T cells rather than an intrinsic defect.
Collapse
Affiliation(s)
- H A Papadaki
- Department of Hematology of the University of Crete School of Medicine, Crete, Greece
| | | | | | | | | | | | | | | | | | | |
Collapse
|